自体骨软骨移植治疗运动员大距骨骨软骨损伤可行
本研究为病例系列(证据等级4),纳入38例距骨骨软骨损伤≥150 mm²的运动员(Tegner>6),采用外侧股骨髁供区自体骨软骨移植,平均随访45个月。
要点
- 自体骨软骨移植可使多数运动员大距骨骨软骨损伤患者恢复伤前运动水平。
- MOCART评分与恢复运动能力强相关,AUC为0.891。
- 取3个骨软骨柱的患者需警惕膝关节供区疼痛风险。
核心结论
- 自体骨软骨移植治疗运动员大距骨骨软骨损伤可行,恢复运动水平、患者满意度和FAOS/VAS评分均良好。
- 恢复运动能力取决于良好的移植物整合。
研究设计与样本
- 病例系列研究,证据等级4。
- 纳入38例职业和业余运动员(Tegner评分>6),距骨骨软骨损伤大小≥150 mm²。
- 手术为自体骨软骨移植,供区来自外侧股骨髁。
- 最少随访24个月,评估恢复运动、VAS疼痛评分和FAOS,术后12个月用MRI MOCART评分评估移植物整合。
主要发现
- 平均随访45个月,平均病灶大小249 mm²。
- 2例出现膝关节供区疼痛,均取3个骨软骨柱。
关键数值与推荐
- 取3个骨软骨柱的患者需注意膝关节供区疼痛风险增加。
临床怎么用
- 对于距骨骨软骨损伤≥150 mm²的运动员,自体骨软骨移植是可考虑的治疗选择,可期待恢复伤前运动水平。
- 术后12个月MOCART评分有助于预测恢复运动能力,评分较高者恢复伤前水平可能性大。
- 取3个骨软骨柱时需告知患者膝关节供区疼痛风险增加。
局限性
- 病例系列研究,证据等级4,样本量有限(38例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autologous osteochondral transplantation (AOT) has been shown to be a viable treatment option for large osteochondral lesions of the talus. However, there are limited data regarding the management of large lesions in an athletic population, notably with regard to return to sport. Our investigation focused on assessing both qualitative and quantitative outcomes in the high-demand athlete with large (>150 mm2) lesions. HYPOTHESIS: AOT is a viable option in athletes with large osteochondral lesions and can allow them to return to sport at their preinjury level. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: The study population was limited to professional and amateur athletes (Tegner score, >6) with a talar osteochondral lesion size of 150 mm2 or greater. The surgical intervention was AOT with a donor site from the lateral femoral condyle. Clinical outcomes at a minimum of 24 months included return to sport, visual analog scale (VAS) for pain score, and Foot and Ankle Outcome Score (FAOS). In addition, graft incorporation was evaluated by magnetic resonance imaging (MRI) using MOCART (magnetic resonance observation of cartilage repair tissue) scores at 12 months after surgery. RESULTS: A total of 38 athletes, including 11 professional athletes, were assessed. The mean follow-up was 45 months. The mean lesion size was 249 mm2. Thirty-three patients returned to sport at their previous level, 4 returned at a lower level compared with preinjury, and 1 did not return to sport (mean return to play, 8.2 months). The VAS improved from 4.53 preoperatively to 0.63 postoperatively (P = .002). FAOSs improved significantly in all domains (P < .001). Two patients developed knee donor site pain, and both had 3 osteochondral plugs harvested. Univariant analysis demonstrated no association between preoperative patient or lesion characteristics and ability to return to sport. However, there was a strong correlation between MOCART scores and ability to return to sport. The area under receiver operating characteristic of the MOCART score and return to play was 0.891 (P = .005), with a MOCART score of 52.50 representing a sensitivity of 0.85 and specificity of 0.80 in determining ability to return to one's previous level of activity. CONCLUSION: Our study suggests that AOT is a viable option in the management of large osteochondral talar defects in an athletic population, with favorable return to sport level, patient satisfaction, and FAOS/VAS scores. The ability to return to sport is predicated upon good graft incorporation, and further research is required to optimize this technique. Our data also suggest that patients should be aware of the increased risk of developing knee donor site pain when 3 osteochondral plugs are harvested.
引用
- Nguyen A, Ramasamy A, Walsh M, et al. Autologous Osteochondral Transplantation for Large Osteochondral Lesions of the Talus Is a Viable Option in an Athletic Population. Am J Sports Med. 2019. PMID: 31671274. doi:10.1177/0363546519881420
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。